USD 14.9
(-2.23%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 90.97 Million USD | -8.73% |
2022 | 98.7 Million USD | -18.85% |
2021 | 121.63 Million USD | 3.7% |
2020 | 117.29 Million USD | -14.49% |
2019 | 137.17 Million USD | -2.18% |
2018 | 140.23 Million USD | 6.2% |
2017 | 132.05 Million USD | 5.38% |
2016 | 125.31 Million USD | -2.08% |
2015 | 127.97 Million USD | -7.31% |
2014 | 138.07 Million USD | -2.18% |
2013 | 141.14 Million USD | 24.73% |
2012 | 113.16 Million USD | 14.63% |
2011 | 98.71 Million USD | -1.8% |
2010 | 100.52 Million USD | -27.18% |
2009 | 138.05 Million USD | -67.51% |
2008 | 424.97 Million USD | 130.74% |
2007 | 184.18 Million USD | -24.85% |
2006 | 245.07 Million USD | -30.91% |
2005 | 354.74 Million USD | 21.21% |
2004 | 292.67 Million USD | -47.21% |
2003 | 554.43 Million USD | -27.54% |
2002 | 765.16 Million USD | -70.35% |
2001 | 2.58 Billion USD | 144.65% |
2000 | 1.05 Billion USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 38.16 Million USD | 54.42% |
2024 Q2 | 14.74 Million USD | -2.22% |
2024 Q1 | 15.08 Million USD | -31.92% |
2023 Q1 | 22.05 Million USD | -2.25% |
2023 Q4 | 22.15 Million USD | -1.6% |
2023 Q3 | 22.51 Million USD | -3.83% |
2023 Q2 | 23.41 Million USD | 6.17% |
2023 FY | 90.07 Million USD | -8.73% |
2022 Q3 | 22.07 Million USD | -7.5% |
2022 Q4 | 22.56 Million USD | 2.18% |
2022 Q1 | 30.2 Million USD | -3.05% |
2022 Q2 | 23.86 Million USD | -20.99% |
2022 FY | 98.7 Million USD | -18.85% |
2021 Q3 | 31.91 Million USD | 6.28% |
2021 Q4 | 31.15 Million USD | -2.37% |
2021 Q2 | 30.03 Million USD | -1.31% |
2021 Q1 | 30.42 Million USD | 5.33% |
2021 FY | 121.63 Million USD | 3.7% |
2020 FY | 117.29 Million USD | -14.49% |
2020 Q1 | 33.06 Million USD | -5.06% |
2020 Q2 | 26.67 Million USD | -19.32% |
2020 Q3 | 28.23 Million USD | 5.85% |
2020 Q4 | 28.88 Million USD | 2.3% |
2019 Q1 | 32.74 Million USD | -3.77% |
2019 FY | 137.17 Million USD | -2.18% |
2019 Q4 | 34.83 Million USD | 0.8% |
2019 Q3 | 34.55 Million USD | 0.52% |
2019 Q2 | 34.37 Million USD | 4.96% |
2018 FY | 140.23 Million USD | 6.2% |
2018 Q4 | 34.03 Million USD | -3.82% |
2018 Q1 | 34.12 Million USD | 3.22% |
2018 Q3 | 35.38 Million USD | 0.81% |
2018 Q2 | 35.09 Million USD | 2.86% |
2017 FY | 132.05 Million USD | 5.38% |
2017 Q4 | 33.05 Million USD | -0.55% |
2017 Q1 | 33.02 Million USD | 8.07% |
2017 Q2 | 32.72 Million USD | -0.91% |
2017 Q3 | 33.24 Million USD | 1.58% |
2016 FY | 125.31 Million USD | -2.08% |
2016 Q4 | 30.56 Million USD | -3.52% |
2016 Q2 | 31.5 Million USD | -0.23% |
2016 Q1 | 31.57 Million USD | -0.06% |
2016 Q3 | 31.67 Million USD | 0.55% |
2015 FY | 127.97 Million USD | -7.31% |
2015 Q2 | 31.57 Million USD | -4.01% |
2015 Q1 | 32.89 Million USD | -6.1% |
2015 Q4 | 31.59 Million USD | 0.62% |
2015 Q3 | 31.39 Million USD | -0.55% |
2014 Q2 | 34.4 Million USD | -2.02% |
2014 FY | 138.07 Million USD | -2.18% |
2014 Q4 | 35.02 Million USD | 6.02% |
2014 Q1 | 35.11 Million USD | 0.25% |
2014 Q3 | 33.03 Million USD | -3.98% |
2013 Q4 | 35.02 Million USD | 1.52% |
2013 FY | 141.14 Million USD | 24.73% |
2013 Q1 | 35.93 Million USD | -53.53% |
2013 Q3 | 34.5 Million USD | -0.31% |
2013 Q2 | 34.61 Million USD | -3.68% |
2012 Q2 | 23.01 Million USD | -1.36% |
2012 FY | 113.16 Million USD | 14.63% |
2012 Q4 | 77.31 Million USD | 232.78% |
2012 Q3 | 23.23 Million USD | 0.93% |
2012 Q1 | 23.33 Million USD | -2.26% |
2011 Q2 | 25.75 Million USD | 2.65% |
2011 FY | 98.71 Million USD | -1.8% |
2011 Q1 | 25.08 Million USD | 9.22% |
2011 Q4 | 23.87 Million USD | -0.86% |
2011 Q3 | 24.08 Million USD | -6.48% |
2010 Q2 | 27.01 Million USD | -2.37% |
2010 Q3 | 22.86 Million USD | -15.36% |
2010 Q4 | 22.97 Million USD | 0.45% |
2010 Q1 | 27.67 Million USD | -4.66% |
2010 FY | 100.52 Million USD | -27.18% |
2009 Q2 | 39.57 Million USD | 5.48% |
2009 FY | 138.05 Million USD | -67.51% |
2009 Q1 | 37.51 Million USD | -67.71% |
2009 Q4 | 29.02 Million USD | -9.12% |
2009 Q3 | 31.93 Million USD | -19.3% |
2008 Q2 | 40 Million USD | -82.63% |
2008 Q1 | 230.32 Million USD | 436.79% |
2008 Q4 | 116.18 Million USD | 202.07% |
2008 Q3 | 38.46 Million USD | -3.86% |
2008 FY | 424.97 Million USD | 130.74% |
2007 Q4 | 42.9 Million USD | -5.79% |
2007 Q1 | 50 Million USD | -11.6% |
2007 Q2 | 45.72 Million USD | -8.57% |
2007 Q3 | 45.54 Million USD | -0.39% |
2007 FY | 184.18 Million USD | -24.85% |
2006 FY | 245.07 Million USD | -30.91% |
2006 Q2 | 62.22 Million USD | -5.71% |
2006 Q3 | 60.28 Million USD | -3.12% |
2006 Q4 | 56.57 Million USD | -6.16% |
2006 Q1 | 65.99 Million USD | 2.2% |
2005 Q2 | 101.78 Million USD | -1.72% |
2005 FY | 354.74 Million USD | 21.21% |
2005 Q1 | 103.55 Million USD | 520.05% |
2005 Q3 | 84.51 Million USD | -16.97% |
2005 Q4 | 64.57 Million USD | -23.59% |
2004 Q4 | -24.65 Million USD | -125.26% |
2004 Q3 | 97.59 Million USD | -9.88% |
2004 Q2 | 108.29 Million USD | -0.12% |
2004 Q1 | 108.42 Million USD | 0.0% |
2004 FY | 292.67 Million USD | -47.21% |
2003 FY | 554.43 Million USD | -27.54% |
2002 FY | 765.16 Million USD | -70.35% |
2001 FY | 2.58 Billion USD | 144.65% |
2001 Q3 | - USD | 0.0% |
2000 FY | 1.05 Billion USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 92.929% |
CareCloud, Inc. | 93.35 Million USD | 2.547% |
HealthEquity, Inc. | 401.74 Million USD | 77.354% |
iCoreConnect Inc. | 15.12 Million USD | -501.551% |
Inovalon Holdings, Inc. | 427.99 Million USD | 78.743% |
Nutex Health, Inc. | 66.54 Million USD | -36.712% |
Omnicell, Inc. | 534.79 Million USD | 82.988% |
OneMedNet Corporation | 8.24 Million USD | -1003.264% |
Progyny, Inc. | 176.61 Million USD | 48.487% |
Renalytix Plc | 29.04 Million USD | -213.278% |
Schrödinger, Inc. | 318.14 Million USD | 71.403% |
Simulations Plus, Inc. | 37.02 Million USD | -145.756% |
SOPHiA GENETICS SA | 117.73 Million USD | 22.728% |
Streamline Health Solutions, Inc. | 31.19 Million USD | -191.693% |
Augmedix, Inc. | 40.3 Million USD | -125.726% |
CareCloud, Inc. | 93.35 Million USD | 2.547% |
Ontrak, Inc. | 29.47 Million USD | -208.665% |
GE HealthCare Technologies Inc. | 5.48 Billion USD | 98.342% |
Sharecare, Inc. | 225.97 Million USD | 59.739% |
Aclarion, Inc. | 4.87 Million USD | -1765.984% |
CareMax, Inc. | 670.05 Million USD | 86.422% |
Bullfrog AI Holdings, Inc. Common Stock | 5.42 Million USD | -1576.314% |
Forian Inc. | 20.59 Million USD | -341.66% |
Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | -1576.314% |
HeartBeam, Inc. | 15.31 Million USD | -494.09% |
GeneDx Holdings Corp. | 224.28 Million USD | 59.436% |
SCWorx Corp. | 2.71 Million USD | -3245.136% |
Minerva Surgical, Inc. | 58.14 Million USD | -56.48% |
Definitive Healthcare Corp. | 546.47 Million USD | 83.352% |
10x Genomics, Inc. | 674.94 Million USD | 86.521% |
Zhongchao Inc. | 13.92 Million USD | -553.468% |
Accolade, Inc. | 306.51 Million USD | 70.318% |
MSP Recovery, Inc. | 565.43 Million USD | 83.91% |
R1 RCM Inc. | 336.6 Million USD | 72.971% |
Privia Health Group, Inc. | 134.31 Million USD | 32.266% |
EUDA Health Holdings Limited | 4.8 Million USD | -1794.161% |
TruBridge, Inc. | 206.17 Million USD | 55.872% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 92.929% |
Sharecare, Inc. | 225.97 Million USD | 59.739% |
Health Catalyst, Inc. | 258.73 Million USD | 64.836% |
GoodRx Holdings, Inc. | 710.34 Million USD | 87.192% |
Premier, Inc. | 683.65 Million USD | 86.692% |
HealthStream, Inc. | 168.02 Million USD | 45.853% |
Certara, Inc. | 254.08 Million USD | 64.194% |
GeneDx Holdings Corp. | 224.28 Million USD | 59.436% |
Ontrak, Inc. | 29.47 Million USD | -208.665% |
SHL Telemedicine Ltd. | 34.26 Million USD | -165.5% |
CareCloud, Inc. | 93.35 Million USD | 2.547% |
EUDA Health Holdings Limited | 4.8 Million USD | -1794.161% |
HeartBeam, Inc. | 15.31 Million USD | -494.09% |
Mangoceuticals, Inc. | 9.65 Million USD | -842.749% |
CareMax, Inc. | 670.05 Million USD | 86.422% |
Healthcare Triangle, Inc. | 18.12 Million USD | -401.953% |
National Research Corporation | 52.52 Million USD | -73.227% |
Aclarion, Inc. | 4.87 Million USD | -1765.984% |
OptimizeRx Corporation | 69.3 Million USD | -31.28% |